Rituximab biosimilar (Gedeon Richter)
利妥昔单抗生物类似药（Gedeon Richter）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRituximab biosimilar (Gedeon Richter)
Drug Alias Name
Classification
Mechanisms of Action +[4]
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGedeon Richter
China Registration ClassN/A
Develop Information
Active CompaniesStada Arzneimittel AgMochda Pharmaceutical Co Ltd
Inactive CompaniesGedeon Richter Plc
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A